{
  "id": [
    "25393244"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "25393244"
  ],
  "pmcid": [
    "PMC4230886"
  ],
  "doi": [
    "10.1371/journal.pntd.0003233"
  ],
  "title": [
    "Clinical features and patient management of Lujo hemorrhagic fever."
  ],
  "authorString": [
    "Sewlall NH, Richards G, Duse A, Swanepoel R, Paweska J, Blumberg L, Dinh TH, Bausch D."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Sewlall NH"
          ],
          "firstName": [
            "Nivesh H"
          ],
          "lastName": [
            "Sewlall"
          ],
          "initials": [
            "NH"
          ],
          "affiliation": [
            "Internal Medicine, Morningside MediClinic, Johannesburg, South Africa; Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa."
          ]
        },
        {
          "fullName": [
            "Richards G"
          ],
          "firstName": [
            "Guy"
          ],
          "lastName": [
            "Richards"
          ],
          "initials": [
            "G"
          ],
          "affiliation": [
            "Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa."
          ]
        },
        {
          "fullName": [
            "Duse A"
          ],
          "firstName": [
            "Adriano"
          ],
          "lastName": [
            "Duse"
          ],
          "initials": [
            "A"
          ],
          "affiliation": [
            "Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa."
          ]
        },
        {
          "fullName": [
            "Swanepoel R"
          ],
          "firstName": [
            "Robert"
          ],
          "lastName": [
            "Swanepoel"
          ],
          "initials": [
            "R"
          ],
          "affiliation": [
            "Department of Medicine, University of Pretoria, Pretoria, South Africa."
          ]
        },
        {
          "fullName": [
            "Paweska J"
          ],
          "firstName": [
            "Janusz"
          ],
          "lastName": [
            "Paweska"
          ],
          "initials": [
            "J"
          ],
          "affiliation": [
            "National Institute of Communicable Disease, Sandringham, South Africa."
          ]
        },
        {
          "fullName": [
            "Blumberg L"
          ],
          "firstName": [
            "Lucille"
          ],
          "lastName": [
            "Blumberg"
          ],
          "initials": [
            "L"
          ],
          "affiliation": [
            "National Institute of Communicable Disease, Sandringham, South Africa."
          ]
        },
        {
          "fullName": [
            "Dinh TH"
          ],
          "firstName": [
            "Thu Ha"
          ],
          "lastName": [
            "Dinh"
          ],
          "initials": [
            "TH"
          ],
          "affiliation": [
            "Centers for Disease control and Prevention, Atlanta, Georgia, United States of America."
          ]
        },
        {
          "fullName": [
            "Bausch D"
          ],
          "firstName": [
            "Daniel"
          ],
          "lastName": [
            "Bausch"
          ],
          "initials": [
            "D"
          ],
          "affiliation": [
            "Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America."
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "11"
      ],
      "volume": [
        "8"
      ],
      "journalIssueId": [
        "2411366"
      ],
      "dateOfPublication": [
        "2014 "
      ],
      "monthOfPublication": [
        "0"
      ],
      "yearOfPublication": [
        "2014"
      ],
      "printPublicationDate": [
        "2014-01-01"
      ],
      "journal": [
        {
          "title": [
            "PLoS neglected tropical diseases"
          ],
          "ISOAbbreviation": [
            "PLoS Negl Trop Dis"
          ],
          "medlineAbbreviation": [
            "PLoS Negl Trop Dis"
          ],
          "NLMid": [
            "101291488"
          ],
          "ISSN": [
            "1935-2727"
          ],
          "ESSN": [
            "1935-2735"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2014"
  ],
  "pageInfo": [
    "e3233"
  ],
  "abstractText": [
    "In 2008 a nosocomial outbreak of five cases of viral hemorrhagic fever due to a novel arenavirus, Lujo virus, occurred in Johannesburg, South Africa. Lujo virus is only the second pathogenic arenavirus, after Lassa virus, to be recognized in Africa and the first in over 40 years. Because of the remote, resource-poor, and often politically unstable regions where Lassa fever and other viral hemorrhagic fevers typically occur, there have been few opportunities to undertake in-depth study of their clinical manifestations, transmission dynamics, pathogenesis, or response to treatment options typically available in industrialized countries.We describe the clinical features of five cases of Lujo hemorrhagic fever and summarize their clinical management, as well as providing additional epidemiologic detail regarding the 2008 outbreak. Illness typically began with the abrupt onset of fever, malaise, headache, and myalgias followed successively by sore throat, chest pain, gastrointestinal symptoms, rash, minor hemorrhage, subconjunctival injection, and neck and facial swelling over the first week of illness. No major hemorrhage was noted. Neurological signs were sometimes seen in the late stages. Shock and multi-organ system failure, often with evidence of disseminated intravascular coagulopathy, ensued in the second week, with death in four of the five cases. Distinctive treatment components of the one surviving patient included rapid commencement of the antiviral drug ribavirin and administration of HMG-CoA reductase inhibitors (statins), N-acetylcysteine, and recombinant factor VIIa.Lujo virus causes a clinical syndrome remarkably similar to Lassa fever. Considering the high case-fatality and significant logistical impediments to controlled treatment efficacy trials for viral hemorrhagic fever, it is both logical and ethical to explore the use of the various compounds used in the treatment of the surviving case reported here in future outbreaks. Clinical observations should be systematically recorded to facilitate objective evaluation of treatment efficacy. Due to the risk of secondary transmission, viral hemorrhagic fever precautions should be implemented for all cases of Lujo virus infection, with specialized precautions to protect against aerosols when performing enhanced-risk procedures such as endotracheal intubation."
  ],
  "affiliation": [
    "Internal Medicine, Morningside MediClinic, Johannesburg, South Africa; Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Electronic-eCollection"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "research-article",
        "Journal Article",
        "Case Reports"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lassa virus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "IP"
                  ],
                  "qualifierName": [
                    "isolation & purification"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Cross Infection"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Arenaviridae Infections"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lassa Fever"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hemorrhagic Fevers, Viral"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DT"
                  ],
                  "qualifierName": [
                    "drug therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "VI"
                  ],
                  "qualifierName": [
                    "virology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Factor VIIa"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Acetylcysteine"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Recombinant Proteins"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Ribavirin"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Antiviral Agents"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "TU"
                  ],
                  "qualifierName": [
                    "therapeutic use"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Fatal Outcome"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Disease Outbreaks"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "South Africa"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "EP"
                  ],
                  "qualifierName": [
                    "epidemiology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Lujo virus"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "DE"
                  ],
                  "qualifierName": [
                    "drug effects"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "IP"
                  ],
                  "qualifierName": [
                    "isolation & purification"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "Antiviral Agents"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Recombinant Proteins"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
          ],
          "registryNumber": [
            "0"
          ]
        },
        {
          "name": [
            "Factor VIIa"
          ],
          "registryNumber": [
            "EC 3.4.21.21"
          ]
        },
        {
          "name": [
            "Acetylcysteine"
          ],
          "registryNumber": [
            "WYQ7N0BPYC"
          ]
        },
        {
          "name": [
            "Ribavirin"
          ],
          "registryNumber": [
            "49717AWG6K"
          ]
        },
        {
          "name": [
            "recombinant FVIIa"
          ],
          "registryNumber": [
            "AC71R787OV"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1371/journal.pntd.0003233"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC4230886"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC4230886?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "Y"
  ],
  "citedByCount": [
    "4"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "Y"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-05-24"
  ],
  "dateOfCreation": [
    "2014-11-14"
  ],
  "firstIndexDate": [
    "2014-11-14"
  ],
  "fullTextReceivedDate": [
    "2014-11-20"
  ],
  "dateOfRevision": [
    "2016-11-25"
  ],
  "electronicPublicationDate": [
    "2014-11-13"
  ],
  "firstPublicationDate": [
    "2014-11-13"
  ]
}